+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Opioid Antagonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 100 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5922768
Description Jump to:

Quick Summary:

In the ever-evolving pharmaceutical landscape, the Opioid Antagonist Drug market stands out for its vital role in addressing pressing health concerns. As senior business executives, understanding the market dynamics of these essential medications is not just about strategic positioning but navigating the public health sphere with informed decisiveness. Our comprehensive report delves into the intricacies of the industry, providing you with the critical knowledge necessary to make informed decisions and stay ahead of the curve.

Our analysis ensues with a thorough geographical examination, presenting key insights across North America, South America, the Asia Pacific, Europe, and MEA. Garnering detailed intelligence on supply and demand, as well as an evaluation of the major players and pricing strategies, empowers your enterprise to optimize your market stance. The inclusion of diverse countries and regions—from the United States and China to Germany and Brazil—ensures that your strategic planning is anchored in a global context. Complemented by an exhaustive competitor analysis, including SWOT profiles of entities ranging from Pfizer to Takeda, this report is your gateway to mastering the Opioid Antagonist Drug market.

This report describes the global market size of Opioid Antagonist Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment, regional supply, demand, major players, price is presented from 2019 to 2029. This report cover following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Opioid Antagonist Drug as well as some small players. The information for each competitor include:
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Hospital
  • Medical Center

Types Segment:

  • Tablet
  • Injection

Companies Covered:

  • Pfizer
  • Conatus Pharmaceuticals
  • Novartis
  • Intercept Pharmaceuticals
  • Allergan
  • Immuron
  • Takeda
  • Gilead Sciences
  • Genfit
  • etc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Opioid Antagonist Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Opioid Antagonist Drug Market in North America (2019-2029)
8.1 Opioid Antagonist Drug Market Size
8.2 Opioid Antagonist Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Opioid Antagonist Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Opioid Antagonist Drug Market in South America (2019-2029)
9.1 Opioid Antagonist Drug Market Size
9.2 Opioid Antagonist Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Opioid Antagonist Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Opioid Antagonist Drug Market in Asia & Pacific (2019-2029)
10.1 Opioid Antagonist Drug Market Size
10.2 Opioid Antagonist Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Opioid Antagonist Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Opioid Antagonist Drug Market in Europe (2019-2029)
11.1 Opioid Antagonist Drug Market Size
11.2 Opioid Antagonist Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Opioid Antagonist Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Opioid Antagonist Drug Market in MEA (2019-2029)
12.1 Opioid Antagonist Drug Market Size
12.2 Opioid Antagonist Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Opioid Antagonist Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Opioid Antagonist Drug Market (2019-2024)
13.1 Opioid Antagonist Drug Market Size
13.2 Opioid Antagonist Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Opioid Antagonist Drug Market Size by Type
Chapter 14 Global Opioid Antagonist Drug Market Forecast (2024-2029)
14.1 Opioid Antagonist Drug Market Size Forecast
14.2 Opioid Antagonist Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Opioid Antagonist Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Opioid Antagonist Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Conatus Pharmaceuticals
15.2.1 Company Profile
15.2.2 Main Business and Opioid Antagonist Drug Information
15.2.3 SWOT Analysis of Conatus Pharmaceuticals
15.2.4 Conatus Pharmaceuticals Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and Opioid Antagonist Drug Information
15.3.3 SWOT Analysis of Novartis
15.3.4 Novartis Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Intercept Pharmaceuticals
15.4.1 Company Profile
15.4.2 Main Business and Opioid Antagonist Drug Information
15.4.3 SWOT Analysis of Intercept Pharmaceuticals
15.4.4 Intercept Pharmaceuticals Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Allergan
15.5.1 Company Profile
15.5.2 Main Business and Opioid Antagonist Drug Information
15.5.3 SWOT Analysis of Allergan
15.5.4 Allergan Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Immuron
15.6.1 Company Profile
15.6.2 Main Business and Opioid Antagonist Drug Information
15.6.3 SWOT Analysis of Immuron
15.6.4 Immuron Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Takeda
15.7.1 Company Profile
15.7.2 Main Business and Opioid Antagonist Drug Information
15.7.3 SWOT Analysis of Takeda
15.7.4 Takeda Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Gilead Sciences
15.8.1 Company Profile
15.8.2 Main Business and Opioid Antagonist Drug Information
15.8.3 SWOT Analysis of Gilead Sciences
15.8.4 Gilead Sciences Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
15.9 Genfit
15.9.1 Company Profile
15.9.2 Main Business and Opioid Antagonist Drug Information
15.9.3 SWOT Analysis of Genfit
15.9.4 Genfit Opioid Antagonist Drug Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Opioid Antagonist Drug Report
Table Data Sources of Opioid Antagonist Drug Report
Table Major Assumptions of Opioid Antagonist Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Opioid Antagonist Drug Picture
Table Opioid Antagonist Drug Classification
Table Opioid Antagonist Drug Applications
Table Drivers of Opioid Antagonist Drug Market
Table Restraints of Opioid Antagonist Drug Market
Table Opportunities of Opioid Antagonist Drug Market
Table Threats of Opioid Antagonist Drug Market
Table COVID-19 Impact For Opioid Antagonist Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Opioid Antagonist Drug
Table Cost Structure Analysis of Opioid Antagonist Drug
Table Key End Users
Table Latest News of Opioid Antagonist Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Opioid Antagonist Drug Market
Table Policy of Opioid Antagonist Drug Market
Table 2019-2029 North America Opioid Antagonist Drug Market Size
Figure 2019-2029 North America Opioid Antagonist Drug Market Size and CAGR
Table 2019-2029 North America Opioid Antagonist Drug Market Size by Application
Table 2019-2024 North America Opioid Antagonist Drug Key Players Revenue
Table 2019-2024 North America Opioid Antagonist Drug Key Players Market Share
Table 2019-2029 North America Opioid Antagonist Drug Market Size by Type
Table 2019-2029 United States Opioid Antagonist Drug Market Size
Table 2019-2029 Canada Opioid Antagonist Drug Market Size
Table 2019-2029 Mexico Opioid Antagonist Drug Market Size
Table 2019-2029 South America Opioid Antagonist Drug Market Size
Figure 2019-2029 South America Opioid Antagonist Drug Market Size and CAGR
Table 2019-2029 South America Opioid Antagonist Drug Market Size by Application
Table 2019-2024 South America Opioid Antagonist Drug Key Players Revenue
Table 2019-2024 South America Opioid Antagonist Drug Key Players Market Share
Table 2019-2029 South America Opioid Antagonist Drug Market Size by Type
Table 2019-2029 Brazil Opioid Antagonist Drug Market Size
Table 2019-2029 Argentina Opioid Antagonist Drug Market Size
Table 2019-2029 Chile Opioid Antagonist Drug Market Size
Table 2019-2029 Peru Opioid Antagonist Drug Market Size
Table 2019-2029 Asia & Pacific Opioid Antagonist Drug Market Size
Figure 2019-2029 Asia & Pacific Opioid Antagonist Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Opioid Antagonist Drug Market Size by Application
Table 2019-2024 Asia & Pacific Opioid Antagonist Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Opioid Antagonist Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Opioid Antagonist Drug Market Size by Type
Table 2019-2029 China Opioid Antagonist Drug Market Size
Table 2019-2029 India Opioid Antagonist Drug Market Size
Table 2019-2029 Japan Opioid Antagonist Drug Market Size
Table 2019-2029 South Korea Opioid Antagonist Drug Market Size
Table 2019-2029 Southeast Asia Opioid Antagonist Drug Market Size
Table 2019-2029 Australia Opioid Antagonist Drug Market Size
Table 2019-2029 Europe Opioid Antagonist Drug Market Size
Figure 2019-2029 Europe Opioid Antagonist Drug Market Size and CAGR
Table 2019-2029 Europe Opioid Antagonist Drug Market Size by Application
Table 2019-2024 Europe Opioid Antagonist Drug Key Players Revenue
Table 2019-2024 Europe Opioid Antagonist Drug Key Players Market Share
Table 2019-2029 Europe Opioid Antagonist Drug Market Size by Type
Table 2019-2029 Germany Opioid Antagonist Drug Market Size
Table 2019-2029 France Opioid Antagonist Drug Market Size
Table 2019-2029 United Kingdom Opioid Antagonist Drug Market Size
Table 2019-2029 Italy Opioid Antagonist Drug Market Size
Table 2019-2029 Spain Opioid Antagonist Drug Market Size
Table 2019-2029 Belgium Opioid Antagonist Drug Market Size
Table 2019-2029 Netherlands Opioid Antagonist Drug Market Size
Table 2019-2029 Austria Opioid Antagonist Drug Market Size
Table 2019-2029 Poland Opioid Antagonist Drug Market Size
Table 2019-2029 Russia Opioid Antagonist Drug Market Size
Table 2019-2029 MEA Opioid Antagonist Drug Market Size
Figure 2019-2029 MEA Opioid Antagonist Drug Market Size and CAGR
Table 2019-2029 MEA Opioid Antagonist Drug Market Size by Application
Table 2019-2024 MEA Opioid Antagonist Drug Key Players Revenue
Table 2019-2024 MEA Opioid Antagonist Drug Key Players Market Share
Table 2019-2029 MEA Opioid Antagonist Drug Market Size by Type
Table 2019-2029 Egypt Opioid Antagonist Drug Market Size
Table 2019-2029 Israel Opioid Antagonist Drug Market Size
Table 2019-2029 South Africa Opioid Antagonist Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Opioid Antagonist Drug Market Size
Table 2019-2029 Turkey Opioid Antagonist Drug Market Size
Table 2019-2024 Global Opioid Antagonist Drug Market Size by Region
Table 2019-2024 Global Opioid Antagonist Drug Market Size Share by Region
Table 2019-2024 Global Opioid Antagonist Drug Market Size by Application
Table 2019-2024 Global Opioid Antagonist Drug Market Share by Application
Table 2019-2024 Global Opioid Antagonist Drug Key Vendors Revenue
Figure 2019-2024 Global Opioid Antagonist Drug Market Size and Growth Rate
Table 2019-2024 Global Opioid Antagonist Drug Key Vendors Market Share
Table 2019-2024 Global Opioid Antagonist Drug Market Size by Type
Table 2019-2024 Global Opioid Antagonist Drug Market Share by Type
Table 2024-2029 Global Opioid Antagonist Drug Market Size by Region
Table 2024-2029 Global Opioid Antagonist Drug Market Size Share by Region
Table 2024-2029 Global Opioid Antagonist Drug Market Size by Application
Table 2024-2029 Global Opioid Antagonist Drug Market Share by Application
Table 2024-2029 Global Opioid Antagonist Drug Key Vendors Revenue
Figure 2024-2029 Global Opioid Antagonist Drug Market Size and Growth Rate
Table 2024-2029 Global Opioid Antagonist Drug Key Vendors Market Share
Table 2024-2029 Global Opioid Antagonist Drug Market Size by Type
Table 2024-2029 Opioid Antagonist Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer
  • Conatus Pharmaceuticals
  • Novartis
  • Intercept Pharmaceuticals
  • Allergan
  • Immuron
  • Takeda
  • Gilead Sciences
  • Genfit

Methodology

Loading
LOADING...

Related Topics

Related Reports

Opioid mu receptor antagonists - Pipeline Insight, 2024 - Product Image

Opioid mu receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Global Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - Forecast 2024-2030 - Product Image

Global Opioid Induced Constipation Market by Active Ingredients, Drug Class, Mode of Administration, Distribution Channel - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Opioid Use Disorder Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Image

Opioid Use Disorder Drugs Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • 181 Pages
  • Global
From
Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032 - Product Image

Opioid Use Disorder - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • 135 Pages
  • Global
From
Global Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region - Product Image

Global Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.